Injections bypass digestion for higher and more predictable levels, while oral forms are easier to access
PlexusDx Semaglutide Injection, starting at just $189/mo (or $149/mo on the 6-month plan) through licensed 503A compounding pharmacies, makes continuous therapy accessible without insurance barriers or membership fees
This comprised of 43% in the placebo group, 31% in the low dose Qsymia group, and 36% in the high dose Qsymia group
doi: 10.3389/fnut.2025.1564177 Received 21 January 2025 Accepted 05 May 2025 Published 27 May 2025 Volume 12 - 2025 Edited by Omar Guzmn Quevedo, Higher Technological Institute of Tacambaro, Mexico Reviewed by Tongtong Li, Zhejiang University of Technology, China Gabriel Araujo-Silva, Universidade Estadual do Amap, Brazil Updates Copyright 2025 Wang, Zhang, He, Zhang, Huang, Wang, Lin, Xiao, Zou and Cui